Table of Contents
ISRN Stroke
Volume 2013, Article ID 858945, 7 pages
http://dx.doi.org/10.1155/2013/858945
Review Article

MicroRNA: Not Far from Clinical Application in Ischemic Stroke

Department of Neurology, Jinling Hospital, Nanjing University School of Medicine, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, China

Received 14 June 2013; Accepted 17 July 2013

Academic Editors: A. Ducruet and A. Slivka

Copyright © 2013 Yun Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. W. Albers, L. B. Goldstein, D. C. Hess et al., “Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies,” Stroke, vol. 42, no. 9, pp. 2645–2650, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. X. Liu, “Beyond the time window of intravenous thrombolysis: standing by or by stenting?” Interventional Neurology, vol. 1, no. 1, pp. 3–15, 2013. View at Google Scholar
  3. V. L. Roger, A. S. Go, D. M. Lloyd-Jones et al., “Executive summary: heart disease and stroke statistics—2012 update: a report from the American Heart Association,” Circulation, vol. 125, no. 1, pp. 188–197, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. T. B. Hansen, T. I. Jensen, B. H. Clausen et al., “Natural RNA circles function as efficient microRNA sponges,” Nature, vol. 495, no. 7441, pp. 384–388, 2013. View at Google Scholar
  5. R. C. Lee, R. L. Feinbaum, and V. Ambros, “The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14,” Cell, vol. 75, no. 5, pp. 843–854, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. D. H. Chitwood and M. C. P. Timmermans, “Small RNAs are on the move,” Nature, vol. 467, no. 7314, pp. 415–419, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. F. B. Gao, “Posttranscriptional control of neuronal development by microRNA networks,” Trends in Neurosciences, vol. 31, no. 1, pp. 20–26, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. H. L. Janssen, H. W. Reesink, E. J. Lawitz et al., “Treatment of HCV infection by targeting microRNA,” The New England Journal of Medicine, vol. 368, pp. 1685–1694, 2013. View at Publisher · View at Google Scholar
  9. Y. Dai, Z. Qiu, Z. Diao et al., “MicroRNA-155 inhibits proliferation and migration of human extravillous trophoblast derived HTR-8/SVneo cells via down-regulating cyclin D1,” Placenta, vol. 33, no. 10, pp. 824–829, 2012. View at Google Scholar
  10. A. Carlsbecker, J. Y. Lee, C. J. Roberts et al., “Cell signalling by microRNA165/6 directs gene dose-dependent root cell fate,” Nature, vol. 465, no. 7296, pp. 316–321, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Guil and M. Esteller, “DNA methylomes, histone codes and miRNAs: tying it all together,” The International Journal of Biochemistry & Cell Biology, vol. 41, no. 1, pp. 87–95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. D. H. Chitwood, F. T. S. Nogueira, M. D. Howell, T. A. Montgomery, J. C. Carrington, and M. C. P. Timmermans, “Pattern formation via small RNA mobility,” Genes & Development, vol. 23, no. 5, pp. 549–554, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Chen, Y. Ba, L. Ma et al., “Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases,” Cell Research, vol. 18, no. 10, pp. 997–1006, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Lee, S. S. Ajay, J. I. Yook et al., “New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites,” Genome Research, vol. 19, no. 7, pp. 1175–1183, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. R. W. Carthew and E. J. Sontheimer, “Origins and mechanisms of miRNAs and siRNAs,” Cell, vol. 136, no. 4, pp. 642–655, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., “Circulating microRNAs as stable blood-based markers for cancer detection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513–10518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Wang, “Targering and targeting miRNAs,” in MicroRNA Interference Techologies, Chapter 1, 2009. View at Google Scholar
  18. L. F. Sempere, S. Freemantle, I. Pitha-Rowe, E. Moss, E. Dmitrovsky, and V. Ambros, “Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation,” Genome Biology, vol. 5, no. 3, article R13, 2004. View at Google Scholar · View at Scopus
  19. Y. Zhang, Y. Ueno, X. S. Liu et al., “The microRNA-17-92 cluster enhances axonal outgrowth in embryonic cortical neurons,” The Journal of Neuroscience, vol. 33, no. 16, pp. 6885–6894, 2013. View at Google Scholar
  20. O. G. Bhalala, M. Srikanth, and J. A. Kessler, “The emerging roles of microRNAs in CNS injuries,” Nature Reviews Neurology, vol. 9, no. 6, pp. 328–339, 2013. View at Publisher · View at Google Scholar
  21. X. Liu, Y. Xiong, Z. Zhou et al., “China interventional stroke registry: rationale and study design,” Cerebrovascular Diseases, vol. 35, no. 4, pp. 349–354, 2013. View at Google Scholar
  22. P. P. Toth, “Insulin resistance, small LDL particles, and risk for atherosclerotic disease,” Current Vascular Pharmacology. In press.
  23. T. A. Harris, M. Yamakuchi, M. Ferlito, J. T. Mendell, and C. J. Lowenstein, “MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 5, pp. 1516–1521, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Rodríguez-Yáñez, T. Sobrino, S. Arias et al., “Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke,” Stroke, vol. 42, no. 10, pp. 2813–2818, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Chen, Z. Huang, L. Wang et al., “MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages,” Cardiovascular Research, vol. 83, no. 1, pp. 131–139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Yanagawa, S. Iwamoto, and K. Nishi, “Pontine infarction induced by injury of the perforating branch of the basilar artery after blunt head impact—case report,” Neurologia Medico-Chirurgica, vol. 48, no. 8, pp. 343–346, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Weber, M. B. Baker, J. P. Moore, and C. D. Searles, “MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity,” Biochemical and Biophysical Research Communications, vol. 393, no. 4, pp. 643–648, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Ji, Y. Cheng, J. Yue et al., “MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation,” Circulation Research, vol. 100, no. 11, pp. 1579–1588, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Walchli, V. Pernet, O. Weinmann et al., “Nogo-A is a negative regulator of CNS angiogenesis,” Proceedings of the National Academy of Sciences of the United States of America, 2013. View at Publisher · View at Google Scholar
  30. P. Dentelli, A. Rosso, F. Orso, C. Olgasi, D. Taverna, and M. F. Brizzi, “MicroRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 8, pp. 1562–1568, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Poliseno, A. Tuccoli, L. Mariani et al., “MicroRNAs modulate the angiogenic properties of HUVECs,” Blood, vol. 108, no. 9, pp. 3068–3071, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Wu, Z. Yang, and G. Li, “Role of specific microRNAs for endothelial function and angiogenesis,” Biochemical and Biophysical Research Communications, vol. 386, no. 4, pp. 549–553, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Bonauer, G. Carmona, M. Iwasaki et al., “MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice,” Science, vol. 324, no. 5935, pp. 1710–1713, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Combs, Y. Jiang, J. Zhu et al., “Tetracycline inhibits local inflammation induced by cerebral ischemia via modulating autophagy,” PLoS ONE, vol. 7, no. 11, Article ID e48672, 2012. View at Google Scholar
  35. K. J. Yin, Z. Deng, M. Hamblin et al., “Peroxisome proliferator-activated receptor δ regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury,” The Journal of Neuroscience, vol. 30, no. 18, pp. 6398–6408, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. K. J. Yin, Z. Deng, H. Huang et al., “MiR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia,” Neurobiology of Disease, vol. 38, no. 1, pp. 17–26, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Buller, X. Liu, X. Wang et al., “MicroRNA-21 protects neurons from ischemic death,” FEBS Journal, vol. 277, no. 20, pp. 4299–4307, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Y. Tan, J. M. Li, R. Stocker, and L. M. Khachigian, “Angiotensin II-inducible smooth muscle cell apoptosis involves the angiotensin II type 2 receptor, GATA-6 activation, and Fasl-Fas engagement,” Circulation Research, vol. 105, no. 5, pp. 422–430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Jin, G. Yang, and G. Li, “Inflammatory mechanisms in ischemic stroke: role of inflammatory cells,” Journal of Leukocyte Biology, vol. 87, no. 5, pp. 779–789, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. M. K. McCoy and M. G. Tansey, “TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease,” Journal of Neuroinflammation, vol. 5, article 45, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Frenkel, Z. Huang, R. Maron et al., “Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells,” The Journal of Immunology, vol. 171, no. 12, pp. 6549–6555, 2003. View at Google Scholar · View at Scopus
  42. A. Valerio, M. Dossena, P. Bertolotti et al., “Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-κB/c-Rel-dependent transcription,” Stroke, vol. 40, no. 2, pp. 610–617, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Neumann, M. Gunzer, H. O. Gutzeit, O. Ullrich, K. G. Reymann, and K. Dinkel, “Microglia provide neuroprotection after ischemia,” FASEB Journal, vol. 20, no. 6, pp. 714–716, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. A. I. Pogue, J. G. Cui, Y. Y. Li, Y. Zhao, F. Culicchia, and W. J. Lukiw, “Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation,” Neuroscience Letters, vol. 476, no. 1, pp. 18–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. W. B. Veldhuis, J. W. Derksen, S. Floris et al., “Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat,” Journal of Cerebral Blood Flow and Metabolism, vol. 23, no. 9, pp. 1029–1039, 2003. View at Google Scholar · View at Scopus
  46. K. W. Witwer, J. M. Sisk, L. Gama, and J. E. Clements, “MicroRNA regulation of IFN-β protein expression: rapid and sensitive modulation of the innate immune response,” The Journal of Immunology, vol. 184, no. 5, pp. 2369–2376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. M. L. Ho, R. Rojas, and R. L. Eisenberg, “Cerebral edema,” American Journal of Roentgenology, vol. 199, no. 3, pp. W258–W273, 2012. View at Google Scholar
  48. S. Sepramaniam, A. Armugam, K. Y. Lim et al., “MicroRNA 320a functions as a novel endogenous modulator of aquaporins 1 and 4 as well as a potential therapeutic target in cerebral ischemia,” The Journal of Biological Chemistry, vol. 285, no. 38, pp. 29223–29230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. A. P. Wojtovich, S. M. Nadtochiy, P. S. Brookes, and K. Nehrke, “Ischemic preconditioning: the role of mitochondria and aging,” Experimental Gerontology, vol. 47, no. 1, pp. 1–7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. U. Dirnagl, K. Becker, and A. Meisel, “Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use,” The Lancet Neurology, vol. 8, no. 4, pp. 398–412, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. S. T. Lee, K. Chu, K. H. Jung et al., “MicroRNAs induced during ischemic preconditioning,” Stroke, vol. 41, no. 8, pp. 1646–1651, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. T. A. Lusardi, C. D. Farr, C. L. Faulkner et al., “Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex,” Journal of Cerebral Blood Flow and Metabolism, vol. 30, no. 4, pp. 744–756, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Jeyaseelan, K. Y. Lim, and A. Armugam, “MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion,” Stroke, vol. 39, no. 3, pp. 959–966, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. D. Z. Liu, Y. Tian, B. P. Ander et al., “Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures,” Journal of Cerebral Blood Flow and Metabolism, vol. 30, no. 1, pp. 92–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. K. S. Tan, A. Armugam, S. Sepramaniam et al., “Expression profile of microRNAs in young stroke patients,” PLoS ONE, vol. 4, no. 11, Article ID e7689, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. J. C. Henry, A. C. P. Azevedo-Pouly, and T. D. Schmittgen, “MicroRNA replacement therapy for cancer,” Pharmaceutical Research, vol. 28, no. 12, pp. 3030–3042, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Xiao, B. Yang, H. Lin, Y. Lu, X. Luo, and Z. Wang, “Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4,” Journal of Cellular Physiology, vol. 212, no. 2, pp. 285–292, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. Jiang, N. Wei, J. Zhu et al., “A new approach with less damage: intranasal delivery of tetracycline-inducible replication-defective herpes simplex virus type-1 vector to brain,” Neuroscience, vol. 201, pp. 96–104, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Zhao, J. Wang, L. Gao et al., “MiRNA-424 protects against permanent focal cerebral ischemia injury in mice involving suppressing microglia activation,” Stroke, vol. 44, no. 6, pp. 1706–1713, 2013. View at Publisher · View at Google Scholar
  60. X. S. Liu, M. Chopp, X. L. Wang et al., “MicroRNA-17-92 cluster mediates the proliferation and survival of neural progenitor cells after stroke,” The Journal of Biological Chemistry, vol. 288, no. 18, pp. 12478–12488, 2013. View at Publisher · View at Google Scholar
  61. M. M. Harraz, S. M. Eacker, X. Wang, T. M. Dawson, and V. L. Dawson, “MicroRNA-223 is neuroprotective by targeting glutamate receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 46, pp. 18962–618967, 2012. View at Publisher · View at Google Scholar
  62. Z. Guo, Z. Wen, A. Qin et al., “Antisense oligonucleotide treatment enhances the recovery of acute lung injury through IL-10-secreting M2-like macrophage-induced expansion of CD4+ regulatory T cells,” The Journal of Immunology, vol. 190, no. 8, pp. 4337–4348, 2013. View at Google Scholar
  63. J. Yue, “MiRNA and vascular cell movement,” Advanced Drug Delivery Reviews, vol. 63, no. 8, pp. 616–622, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Dharap, K. Bowen, R. Place, L. C. Li, and R. Vemuganti, “Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome,” Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 4, pp. 675–687, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. B. Ouyang, Y. Lu, S. Yue et al., “MiR-181 regulates GRP78 and influences outcome from cerebral ischemia in vitro and in vivo,” Neurobiology of Disease, vol. 45, no. 1, pp. 555–563, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. A. Selvamani, P. Sathyan, R. C. Miranda, and F. Sohrabji, “An antagomir to microRNA let7f promotes neuroprotection in an ischemic stroke model,” PLoS ONE, vol. 7, no. 2, Article ID e32662, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. G. Pandi, V. P. Nakka, A. Dharap, A. Roopra, and R. Vemuganti, “MicroRNA miR-29c down-regulation leading to de-repression of its target DNA methyltransferase 3a promotes ischemic brain damage,” PLoS ONE, vol. 8, no. 3, Article ID e58039, 2013. View at Google Scholar
  68. J. Krützfeldt, M. N. Poy, and M. Stoffel, “Strategies to determine the biological function of microRNAs,” Nature Genetics, vol. 38, supplement, pp. S14–S19, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. Jiang, N. Wei, T. Lu, J. Zhu, G. Xu, and X. Liu, “Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats,” Neuroscience, vol. 172, pp. 398–405, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Jiang, J. Zhu, G. Xu, and X. Liu, “Intranasal delivery of stem cells to the brain,” Expert Opinion on Drug Delivery, vol. 8, no. 5, pp. 623–632, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. S. I. Savitz, J. Dinsmore, J. Wu, G. V. Henderson, P. Stieg, and L. R. Caplan, “Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study,” Cerebrovascular Diseases, vol. 20, no. 2, pp. 101–107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. X. Liu, “Clinical trials of intranasal delivery for treating neurological disorders—a critical review,” Expert Opinion on Drug Delivery, vol. 8, no. 12, pp. 1681–1690, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. S. T. Lee, K. Chu, K. H. Jung et al., “MiR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model,” Annals of Neurology, vol. 72, no. 2, pp. 269–277, 2012. View at Google Scholar